Literature DB >> 2157061

cDNA cloning and transient expression of the Epstein-Barr virus-determined nuclear antigen EBNA3B in human cells and identification of novel transcripts from its coding region.

B Kerdiles1, D Walls, H Triki, M Perricaudet, I Joab.   

Abstract

Recombinant plasmids containing sequences from the BamHI-E rightward reading frames 2a and 2b (BERF2a and 2b) of the Epstein-Barr virus (EBV) genome were isolated from a library of cDNA clones which had been previously made from the EBV B95-8 lymphoblastoid cell line (M. Bodescot, O. Brison, and M. Perricaudet, Nucleic Acids Res. 14:7103-7114, 1986). The characterization of these clones in combination with RNase mapping experiments led to the identification of one leftward and several rightward transcripts traversing the EBV-determined nuclear antigen EBNA3B coding region. One cDNA (T7) contains a continuous open reading frame generated by the splicing together of BERF2a and BERF2b. The T7 clone was used to reconstruct a complete fused BERF2a/2b open reading frame in an adenovirus-based expression vector. Western immunoblotting and immunofluorescence experiments using human 293 cells showed that the recombinant plasmid is capable of expressing a protein with a size, immunological characteristics, and a subcellular localization indistinguishable from those of native B95-8 EBNA3B.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2157061      PMCID: PMC249320          DOI: 10.1128/JVI.64.4.1812-1816.1990

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  15 in total

1.  BamHI E region of the Epstein-Barr virus genome encodes three transformation-associated nuclear proteins.

Authors:  A Ricksten; B Kallin; H Alexander; J Dillner; R Fåhraeus; G Klein; R Lerner; L Rymo
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

2.  Distinction between Epstein-Barr virus type A (EBNA 2A) and type B (EBNA 2B) isolates extends to the EBNA 3 family of nuclear proteins.

Authors:  M Rowe; L S Young; K Cadwallader; L Petti; E Kieff; A B Rickinson
Journal:  J Virol       Date:  1989-03       Impact factor: 5.103

3.  An Epstein-Barr virus transcription unit is at least 84 kilobases long.

Authors:  M Bodescot; O Brison; M Perricaudet
Journal:  Nucleic Acids Res       Date:  1986-03-25       Impact factor: 16.971

4.  Definitive identification of a member of the Epstein-Barr virus nuclear protein 3 family.

Authors:  K Hennessy; F Wang; E W Bushman; E Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

5.  Epstein-Barr virus mRNAs produced by alternative splicing.

Authors:  M Bodescot; M Perricaudet
Journal:  Nucleic Acids Res       Date:  1986-09-11       Impact factor: 16.971

6.  A fifth Epstein-Barr virus nuclear protein (EBNA3C) is expressed in latently infected growth-transformed lymphocytes.

Authors:  L Petti; J Sample; F Wang; E Kieff
Journal:  J Virol       Date:  1988-04       Impact factor: 5.103

7.  Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter.

Authors:  D A Melton; P A Krieg; M R Rebagliati; T Maniatis; K Zinn; M R Green
Journal:  Nucleic Acids Res       Date:  1984-09-25       Impact factor: 16.971

8.  Mapping of the gene coding for Epstein-Barr virus-determined nuclear antigen EBNA3 and its transient overexpression in a human cell line by using an adenovirus expression vector.

Authors:  I Joab; D T Rowe; M Bodescot; J C Nicolas; P J Farrell; M Perricaudet
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

9.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

10.  Identification of Epstein-Barr virus sequences that encode a nuclear antigen expressed in latently infected lymphocytes.

Authors:  J C Hearing; J C Nicolas; A J Levine
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

View more
  5 in total

1.  A conserved domain of the Epstein-Barr virus nuclear antigens 3A and 3C binds to a discrete domain of Jkappa.

Authors:  B Zhao; D R Marshall; C E Sample
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

2.  Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation.

Authors:  B Tomkinson; E Robertson; E Kieff
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

3.  Identification of a short amino acid sequence essential for efficient nuclear targeting of the Epstein-Barr virus nuclear antigen 3A.

Authors:  A Le Roux; M Berebbi; M Moukaddem; M Perricaudet; I Joab
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

4.  Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes.

Authors:  J Sample; L Young; B Martin; T Chatman; E Kieff; A Rickinson; E Kieff
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

5.  Use of second-site homologous recombination to demonstrate that Epstein-Barr virus nuclear protein 3B is not important for lymphocyte infection or growth transformation in vitro.

Authors:  B Tomkinson; E Kieff
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.